Trials / Completed
CompletedNCT00142558
A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)
A Randomized, Double-Blind, Active-Comparator-Controlled 5-Day Trial of the Effect of Etoricoxib 120 mg Versus Indomethacin 150 mg in the Treatment of Acute Gout
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 180 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study to evaluate the effects of etoricoxib and indomethacin in the treatment of acute gout.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0663; etoricoxib / Duration of Treatment: 5 Days | |
| DRUG | Comparator: indomethacin 75 mg sustained release capsule / Duration of Treatment: 5 Days |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2005-05-01
- Completion
- 2005-05-01
- First posted
- 2005-09-02
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00142558. Inclusion in this directory is not an endorsement.